20.03.2015 • NewsDede WillamsAbbVieBiotechnology

AbbVie and Puerto Rico Announce $30 Million Expansion

AbbVie is expanding an existing site in Puerto Rico at a cost of $30 million, adding to its capacity for biotechnology.

The proposed expansion will take place in AbbVie's site located in the northern municipality of Barceloneta, already home to two of the company's state-of-the-art facilities.

According to Stephen Muldoon, vice president of engineering and operations, the company is focused on "providing a significant impact on patients."

Puerto Rico Industrial Development Company (PRIDCO) is promoting the expansion with incentives for job creation and infrastructure.

"AbbVie's expansion in Barceloneta is very important for us, as this site is one of the world's most advanced biopharmaceutical facilities, contributing to our island's growing reputation as a biotech hub," said Puerto Rico governor Alejandro García Padilla.

The US drugmaker established its first manufacturing facility on the island in 1969. In addition to its commercial presence, the company has three manufacturing plants on the island. Together the three sites manufacture 13 products that support the therapeutic areas of immunology, virology and metabolic disorders.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.